Scotty, while I'm inclined to agree with you, it's been a few years since I mentioned it to my back surgeon, who's also a brain surgeon, and I found he knew nothing about it. When I mentioned Dr. Liau's name he not only knew her, but had worked with her and almost immediately he and many working with him became investors. I believe that you're right, brain surgeons throughout the world will get the word on the UK approval and they'll help push for approval elsewhere. I also believe they'll learn of the use of Poly-ICLC and/or Keytruda to enhance the benefits with our vaccine dramatically.
In the beginning, I very much doubt that the supply will be able to keep up with the demand until the EDEN unit becomes available. The biggest sales force in the world is useless if product cannot be delivered. With UK approval sales will be met through Sawston and provide some of the funding needed for the company to pursue the additional approvals which combined with EDEN approval will permit more product to be delivered elsewhere. I'm still of the belief that it will be CRL who'll be doing this production, storage and delivery. As for sales, as the word spreads to the worlds brain surgeons, little selling will be necessary, managing to satisfy the demand may become the tougher task as patients and their Drs. may be unhappy with being told their vaccine is scheduled for manufacture several months from now. A legal question may need to be answered as to whether it's acceptable to accept an additional payment for priority manufacture of the vaccine, if so, I would expect wealthier patients will make such payments.
Gary
News 
Market Data 
Discover 
